Diagnostic News and Research

RSS

Diatron introduces advanced RUO indices on its Aquila, Aquarius 3, Abacus 5 analyzers

Diatron, a STRATEC brand specializing in the development, manufacturing, and marketing of hematology and clinical chemistry analyzers and related reagents for human and veterinary use, expands the capabilities of its Aquila, Aquarius 3, and Abacus 5 hematology analyzers with six advanced hematological indices.

From Diatron 29 Apr 2026

AI eye screening shows promise for detecting six metabolic diseases

Researchers developed Reti-Pioneer, an AI retinal imaging framework that screened for six endocrine and metabolic diseases using color fundus photographs and clinical metadata. The system showed moderate-to-strong performance across cohorts, improved specialist decision-making, and demonstrated promising, though still preliminary, potential for faster, scalable disease screening.

29 Apr 2026

Study reframes ADHD as disorder of energy regulation

The number of people in Europe diagnosed with attention deficit hyperactivity disorder (ADHD) has continued to rise steadily, not only among children, but increasingly among adults and women.

28 Apr 2026

New optical imaging tool allows real-time breast cancer staging

Sentinel lymph node biopsy (SLNB) is critical to breast cancer staging, yet current assessment methods remain heavily dependent on pathology expertise and time-consuming tissue processing.

28 Apr 2026

FINGERS-7B to eradicate Alzheimer's symptoms

Alzheimer's disease is best addressed as early as possible, ideally before symptoms become apparent. To enable early, accurate risk prediction both for individuals and whole populations, a team of AI researchers, physicians, and scientists centered at MIT has released FINGERS-7B, the first AI foundation model built to make Alzheimer's preventable.

28 Apr 2026

Newer mail-in stool tests increase colorectal cancer screening completion rates

Colorectal cancer (CRC) is the second most common cause of cancer death in the United States and disproportionally impacts people who receive care in under-resourced settings.

27 Apr 2026

New blood filtering treatment safely extends pregnancy in severe preeclampsia

Cedars-Sinai Health Sciences University investigators have developed and successfully tested a new treatment for pregnant women with severe early preeclampsia, a leading cause of premature birth as well as maternal and fetal death.

27 Apr 2026

Natural compound obakulactone shows therapeutic potential for rheumatoid arthritis

A new study published in Engineering reveals that obakulactone (OL), a natural tetracyclic triterpenoid isolated from Phellodendri cortex, exerts a therapeutic effect on rheumatoid arthritis (RA) by promoting the degradation of acyl coenzyme A thioesterase 1 (ACOT1) via the ubiquitin‒proteasome pathway and restoring the homeostasis of unsaturated fatty acids.

25 Apr 2026

Shared brain connectivity patterns found across major neurodevelopmental disorders

Differences in brain connectivity are linked to several neurodevelopmental disorders, yet scientists still struggle to determine what changes are shared or unique to each condition.

25 Apr 2026

Brain-Gut Health Initiative supports AI-assisted diagnosis of psychiatric disorders

Psychiatric disorders affect millions worldwide, but their diagnosis still relies on clinical observation instead of standard biological tests.

25 Apr 2026

New biorepository approach advances research on sudden cardiac arrest

A cutting-edge University of Cincinnati College of Medicine study has shown how emergency medicine researchers can partner with community emergency medical services nationwide to investigate the causes of sudden cardiac arrest.

24 Apr 2026

WHO prequalifies first malaria treatment designed for youngest vulnerable patients

Ahead of World Malaria Day on 25 April, the World Health Organization (WHO) has announced a significant step forward in the fight against malaria with the prequalification of the first treatment developed specifically for newborns and young infants weighing between two and five kilograms.

24 Apr 2026

Novel algorithm improves detection of moderate-to-severe aortic stenosis

A novel detection algorithm spotted moderate-to-severe aortic stenosis (AS) with a sensitivity of 90.5% of all patients and 100% of African American patients.

24 Apr 2026

Study reframes Hodgkin lymphoma as a cancer of failed cell development

For the first time, Weill Cornell Medicine researchers have demonstrated that Hodgkin lymphoma cancer cells from patient samples are immune cells stuck in an "identity crisis."

24 Apr 2026

New model improves detection of Li-Fraumeni Syndrome risk

In a prospective validation study, researchers at The University of Texas MD Anderson Cancer Center demonstrated that a new mathematical model, called LFSPRO, was effective in supporting genetic counselor decision-making and more accurately predicted individuals at higher risk of Li-Fraumeni Syndrome (LFS), a hereditary condition that carries a higher risk of developing multiple cancers.

23 Apr 2026

Many heart scans fail to provide clear diagnostic results

Thousands of patients sent for vital heart scans may be undergoing unnecessary first-line tests that fail to deliver clear answers - according to new research from the University of East Anglia.

23 Apr 2026

Study highlights gaps in opioid use disorder care during pregnancy

Opioid use disorder during pregnancy remains a critical yet under-addressed public health issue in the U.S., according to a new study at Columbia University Mailman School of Public Health.

23 Apr 2026

APOLLO AI learns from 25 billion medical events to predict future disease

APOLLO is a multimodal temporal foundation model trained on 25.2 billion medical events from 7.2 million patients across 33 years of Mass General Brigham records, integrating 28 medical modalities into unified “virtual patient representations.” Across 322 downstream tasks, the model showed strong performance in disease prediction, treatment-response stratification, hospital operations, and patient retrieval, supporting the idea of more computable, data-driven medicine.

23 Apr 2026

Specific intestinal fungi play role in the pathogenesis of MASLD and cardiovascular disease

Metabolic dysfunction-associated steatotic liver disease (MASLD) is an independent risk factor for cardiovascular disease (CVD). While gut bacteria have been linked to CVD, the role of intestinal fungi in subclinical coronary atherosclerosis (SCA) remains unclear.

23 Apr 2026

Exercise may be safer for children with heart conditions

Physical activity in children and teenagers with cardiomyopathy (conditions that affect the heart muscle's structure and function, impairing its ability to pump or fill effectively), as well as children with implantable cardioverter-defibrillators (ICDs) may be safer than previous research suggested, according to a new scientific statement from the American Heart Association, published today in the Association's flagship peer-reviewed journal Circulation.

23 Apr 2026